Monitoring Drug-induced Uveitis
NCT03899922 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2023-04-05
Summary
Several drugs and chemotherapies seem to induce uveitis. This study investigates reports of uveitis, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).
Conditions
- Uveitis
- Uveitis Drug-Induced
- Eye Diseases
- Uvea--Diseases
Interventions
- DRUG
-
Drugs inducing uveitis
Drugs susceptible to induce uveitis
Sponsors & Collaborators
-
Groupe Hospitalier Pitie-Salpetriere
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2020-04-01
- Completion
- 2023-04-04
- FDA Drug
- Yes
Countries
- France
Study Locations
More Related Trials
-
Intravitreal Bevacizumab in Agioid Streaks
NCT00406250 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Bevacizumab for Neovascular Glaucoma
NCT00384631 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
NCT00727753 ·Status: COMPLETED
-
Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea
NCT01501760 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
NCT00524875 ·Status: UNKNOWN ·Phase: NA
-
Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
NCT01994174 ·Status: TERMINATED
-
Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis
NCT03897192 ·Status: COMPLETED
-
VEGF and PEDF in Patients With Myopic Choroidal Neovascularization
NCT02175940 ·Status: COMPLETED
-
Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema
NCT01095809 ·Status: TERMINATED ·Phase: PHASE3
-
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
NCT00599820 ·Status: TERMINATED ·Phase: PHASE3
-
Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor
NCT03793400 ·Status: COMPLETED
-
Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
NCT00370201 ·Status: UNKNOWN ·Phase: PHASE3
-
Functional and Morphologic Aspects of Intravitreal Triamcinolone for Uveitis-associated Cystoid Macular Edema
NCT01299129 ·Status: COMPLETED
-
Pain and Visual Outcome in Intravitreal Bevacizumab Injection
NCT02790775 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
NCT07161544 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema
NCT00893854 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
NCT02390531 ·Status: COMPLETED ·Phase: PHASE1
-
Aflibercept and Bevacizumab for Diabetic Maculopathies
NCT06850571 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT05714904 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
NCT00407121 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Injections by Nurses and Physicians Compared
NCT02359149 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
NCT00645697 ·Status: COMPLETED
-
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
NCT02033018 ·Status: UNKNOWN ·Phase: PHASE4
-
Ocular Discomfort Assessment After Intravitreal Injections
NCT02806830 ·Status: COMPLETED ·Phase: NA